NBER WORKING PAPER SERIES

INFORMATION TECHNOLOGY AND PATIENT HEALTH:
ANALYZING OUTCOMES, POPULATIONS, AND MECHANISMS
Seth Freedman
Haizhen Lin
Jeffrey Prince
Working Paper 21389
http://www.nber.org/papers/w21389
NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
July 2015

We acknowledge the Health Information Management Systems Society (HIMSS) for providing access
and assistance to their data. Freedman is grateful to the Robert Wood Johnson Foundation Scholars
in Health Policy Research Program for financial support in purchasing data. We also thank Leila Agha,
Lenisa Chang, Chris Forman, Shane Greenstein, Avi Goldfarb, Jeffrey McCullough, and participants
at NBER SI 2013, WHITE 2013, ASHEcon 2014, IIOC 2014, the University of Massachusetts, Ball
State University, and Purdue University for useful discussion and comments. Noah Hammarlund provided
excellent research assistance. The views expressed herein are those of the authors and do not necessarily
reflect the views of the National Bureau of Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official
NBER publications.
¬© 2015 by Seth Freedman, Haizhen Lin, and Jeffrey Prince. All rights reserved. Short sections of text,
not to exceed two paragraphs, may be quoted without explicit permission provided that full credit,
including ¬© notice, is given to the source.

Information Technology and Patient Health: Analyzing Outcomes, Populations, and Mechanisms
Seth Freedman, Haizhen Lin, and Jeffrey Prince
NBER Working Paper No. 21389
July 2015
JEL No. I10,O33
ABSTRACT
We study the effect of hospital adoption of electronic medical records (EMRs) on health outcomes,
particularly patient safety indicators (PSIs). We find evidence of a positive impact of EMRs on PSIs
via decision support rather than care coordination. Consistent with this mechanism, we find an EMR
with decision support is more effective at reducing PSIs for less complicated cases, using several different
metrics for complication. These findings indicate the negligible impacts for EMRs found by previous
studies focusing on the Medicare population and/or mortality do not apply in all settings.
Seth Freedman
School of Public and Environmental Affairs
Indiana University
1315 E. 10th St.
Bloomington, IN 47405
freedmas@indiana.edu
Haizhen Lin
Department of Business Economics
and Public Policy
Kelley School of Business
Indiana University
1309 East Tenth Street
Bloomington, IN 47405
and NBER
hzlin@indiana.edu

Jeffrey Prince
Kelley School of Business
Indiana University
1309 E. Tenth St.
Bloomington, IN 47405
jeffprin@indiana.edu

1. Introduction
The increasing availability and adoption of electronic medical records (EMRs) of various
forms has generated substantial optimism concerning possible consequent improvements in
productivity, costs, and quality within the healthcare sector (e.g., Hillestad et al., 2005). This
optimism has proven substantial enough to even spur the passage of the Health Information
Technology for Economic and Clinical Health (HITECH) Act in 2009, which includes
substantial financial incentives for adoption. In contrast, the extant literature measuring various
impacts of EMR adoption provides little indication of dramatic returns (e.g., Ahga 2014,
McCullough et al. 2010, McCullough et al. 2013, Parente and McCullough 2009). However, the
scope of these analyses, particularly with regard to health outcomes, has largely been limited due
to data constraints. In particular, previous studies have focused on mortality among Medicare
patients as the primary health outcome, and large-scale studies generally have focused only on
the Medicare population. The lone large-scale study that we are aware of using data from nonMedicare patients is Miller and Tucker (2011), who find that the availability of EMRs within a
county decreases infant mortality rates.
In this study, we build and utilize a newly integrated dataset to analyze the effect of EMR
adoption on health outcomes for a broader patient population, and for less severe, more common
adverse health outcomes known as patient safety indicators (PSIs). Our data allow us to examine
whether EMR adoption impacts PSIs for the general population, and whether the size of the
impact varies according to a patient‚Äôs level of ‚Äúcomplication,‚Äù measured in several different
ways. Further, by examining multiple health outcomes (i.e., PSIs, inpatient mortality, and length
of stay), different types of EMRs, and accounting for differing levels of patient complication, we
are able to learn more about potential mechanisms through which EMRs impact health outcomes.
2

In particular, EMRs may impact health outcomes via decision support and/or care coordination,
and these mechanisms, if at work, have different implications based on health outcome, EMR,
and patient complication. We can then test these implications against what we observe in the
data to distinguish the channels through which EMRs have an impact.
Expanding the population and type of health outcome for which we have an empirical
assessment of EMRs‚Äô effectiveness, along with an improved understanding of the mechanisms
by which they operate, can have a significant impact on public policy and subsequent EMR
research. It can have a powerful impact on how the U.S. government should be setting policy as
pertains to EMR. In particular, it will help to better assess the potential social value of incentive
programs and whether targeted incentives may be warranted. Further, it can help inform
hospitals‚Äô adoption decisions and potentially patients‚Äô choice of hospitals.
To our knowledge, our study is the first that combines data on EMR adoption with a
nationally representative sample of hospital discharges and examines the effects of hospital EMR
adoption on such a broad patient population. Our primary data sets include the 2003 through
2010 Health Information and Management Systems Society (HIMSS) Analytics Database and
the Nationwide Inpatient Sample (NIS) collected by the Agency for Healthcare Research and
Quality‚Äôs (AHRQ) Healthcare Cost and Utilization Project (HCUP). Beyond construction of a
novel and integrated dataset, the other primary innovation of our study is the direction in which it
takes analysis of the effects of EMR adoption. Prior work has consistently analyzed the effects
of EMR adoption for very specific subgroups of the population ‚Äì in particular, the senior
population or very small groups of hospitals. Like McCullough et al. (2013), which does explore
heterogeneity of impacts within the Medicare population, our study calls attention to the real and

3

consequential possibility that EMR adoption may have different impacts across various
population subgroups depending on the underlying mechanisms.
To test for the effect of EMR adoption on PSIs, we employ a fixed effect approach,
exploiting the fact that many hospitals adopted new EMR systems during our time period. We
are therefore able to control for fixed differences between adopting and non-adopting hospitals
and identify how adopting an EMR changes PSI rates within the adopting hospital. In addition to
estimating the overall effect of EMR adoption on PSIs, we estimate the relationship separately
according to patient complication (measured by age, complexity, diagnosis commonality, and
severity). Our empirical analysis focuses on two EMR applications, Computerized Physician
Order Entry (CPOE) and Physician Documentation, which have experienced significant
increases in adoption during our study period. We find that CPOE significantly decreases the
occurrence of preventable adverse events as measured by PSIs for non-complicated cases. For
example, CPOE is associated with a 12% drop in the probability of experiencing at least one
postoperative adverse event for cases with no more than one comorbidity.
This finding stands in contrast to previous results focusing on mortality as an outcome
and suggests that EMRs indeed have important effects on patient outcomes less severe than
mortality. Assuming decision support is more likely to be helpful for less complicated cases, in
which standard treatment guidelines can play a larger role relative to care coordination, this
finding is also suggestive of decision support playing an important role in EMR effectiveness.
This notion is further corroborated by the fact that we do not find comparable effects for
Physician Documentation, given CPOE is more amenable to decision support while Physician
Documentation is more amenable to care coordination.

4

Our findings suggest interesting implications about the effectiveness of EMRs in
improving health outcomes and provide an important new set of findings to complement the
growing literature on the effect of EMRs on health outcomes. First, our findings suggest that
EMRs play a role in improving patient wellbeing by decreasing preventable adverse events
among the non-senior population. A significant group of previous studies has focused largely on
the senior population and has lacked strong evidence of quality improvement. 1 For example,
Agha (2014) finds little effect of EMR adoption on patient mortality, medical complication rates,
adverse drug events, and readmission rates. McCullough et al. (2010) find some evidence of
improvement in quality measures, but temper this finding by concluding that achieving
substantive benefits from EMR adoption at a national level may be a lengthy process. Parente
and McCullough (2009) find some improvement in patient safety due to EMR adoption, but
conclude there is not enough evidence to draw a strong link between EMR and improvements in
patient safety for the Medicare population. 2 Different from these studies, our paper examines
health effects for a broadly defined, nationally representative population. In addition, we focus
on patient safety, which is arguably a more relevant measure for the non-senior population and
can shed light on the impacts of EMRs on important, but non-deadly, adverse health events.
Second, our results highlight the importance of exploring heterogeneity among
population subgroups, especially when considering different mechanisms through which EMRs
may be expected to impact different patients. Our finding that some EMR applications are more
impactful for less complicated patients suggests that the decision support functions of EMRs do
lead to improved patient outcomes. This finding complements previous findings of McCullough
1

Other studies on health outcomes have included the non-senior population and found more positive findings, but
have utilized small, focused sets of data, primarily within a single hospital setting (e.g., Bates et al. 1998, Bates et al.
1999, and Simeonova and Koulayev 2013).
2
Their study was limited to a sample of Medicare patients during 1999 and 2002. They also study a different set of
EMRs such as nurse charts and picture archiving and communications systems.

5

et al. (2013), who explore heterogeneity for four high-frequency and high-severity diagnoses
within the Medicare population. They find that EMRs reduce mortality for the highest severity
Medicare patients, particularly those with diagnoses that require information management and
care coordination. Our inclusion of a younger, less complex patient population and focus on
outcomes for which decision support may be more beneficial allows us to empirically assess an
additional channel through which EMRs improve patient care. Taken together these studies
suggest that advanced EMRs can be beneficial beyond basic patient data collection. Moreover,
EMRs are likely to impact different types of patients through different mechanisms.
Third, our paper is also related to the existing studies on the effect of EMRs on cost of
care. Despite some relatively sanguine findings concerning costs (e.g., Wang et al. 2003 and
Chaudhry et al. 2006), the majority of the literature suggests cost savings have been small or
non-existent (see Sidorov 2006 for a literature review and Agha 2014 for a more recent study). It
is noteworthy that Dranove et al. (2012) find that EMRs, on average, generate a slight increase in
operational costs. However, this average effect is a combination of cost reductions for hospitals
in ‚Äúfavorable‚Äù locations (i.e., due to IT complementarities) and large cost increases for hospitals
in ‚Äúunfavorable‚Äù locations. As discussed below, patient safety indicators have been linked to
longer hospital stays and higher hospital charges (Zhan and Miller 2003). Therefore, our results
also have implications for EMRs‚Äô role in reducing the cost of care by limiting adverse events
with additional downstream costs.
Our paper lastly contributes to the broader literature on the effect of information
technology (IT). In the healthcare setting, Athey and Stern (2002) find IT linking 911 caller
identification to a location database speeds emergency response and reduces short-term mortality
and hospital costs. Javitt et al. (2008) examine a randomized implementation of decision support

6

tools within an HMO population and find that these tools reduce costs and improve quality. IT
has also been studied in other settings such as banking (Autor et al. 2002) and trucking (Baker
and Hubbard 2003 and Hubbard 2003). Particularly, Autor et al. (2003) find that IT substitutes
for labor in routine tasks and complements labor in non-routine tasks which involves problemsolving and complex communication. In our study, we find that EMRs improve health outcomes
through clinical decision support, a mechanism consistent with complementarities between IT
and skilled labor inputs. Our findings also have potentially broader implications in light of recent
work distinguishing communication technologies from information technologies (Bloom et al.
2014). Specifically, it is natural to view EMRs facilitating care coordination as communication
technologies, and EMRs facilitating decision support as information technologies. Bloom et al.
(2014) find that the former technologies work toward firm centralization while the latter work
toward firm decentralization. To the extent that this insight applies to hospitals, our findings
suggest that the EMRs tending toward decentralization (CPOE) have proven particularly
effective, at least for some health outcomes.

2. Electronic Medical Records and Health Outcomes
2.1. What are EMR Technologies?
As noted in Dranove et al. (2012), an electronic medical record (EMR) is a ‚Äúcatchall
expression used to characterize a wide range of technologies used by hospitals to keep track of
utilization, costs, outcomes, and billings.‚Äù Some technologies generally classified as EMRs
include: Enterprise EMR, Clinical Data Repository (CDR), Clinical Decision Support System
(CDSS), Order Entry, Computerized Practitioner Order Entry (CPOE), and Physician

7

Documentation. Wang (2012) considers all six of these technologies in her analysis, and
Dranove et al. (2012) consider all but Enterprise EMR.
The functionality of these EMR technologies perhaps is best presented via categorization.
Both Dranove et al. (2012) and Wang (2012) break EMR technologies into two broad groups,
which can essentially be labeled ‚Äúbasic‚Äù and ‚Äúadvanced.‚Äù The basic group includes Enterprise
EMR, CDR, CDSS, and Order Entry, and the advanced group includes CPOE and Physician
Documentation. As Wang (2012) describes, this basic group contains applications that ‚Äúcan be
used to store, organize and retrieve patients‚Äô information‚Äù and the advanced group presents
medical history, recommends drugs, and helps health care providers make better decisions.
Dranove et al. (2012) note that these advanced applications ‚Äúare more difficult to implement and
more difficult to operate successfully due to the need for physician training and involvement.‚Äù 3
We focus our analysis on more advanced applications (CPOE and Physician
Documentation) for two reasons. First, as detailed in Section 3, diffusion of more advanced
technologies is more relevant to our study period, which covers more recent years than many
previous studies. Second, recent policy incentivizing EMR adoption and utilization requires
providers to demonstrate advanced capabilities above and beyond digitization of patient data.
Our main analysis examines CPOE specifically, as it is expected to have direct links to patient
outcomes. As described in McCullough et al. (2013), CPOE allows physicians to directly input
orders, potentially reducing miscommunication and errors. Additionally, rules-based protocols,
treatment guidelines, and prescription error checking are often built into CPOE products. 4 These

3

It is worth noting that Agha (2014) has a slightly different means of characterizing these technologies. Her first
group consists of applications whose primary functions are record keeping; and the second being Clinical Decision
Support (CDS) whose primary functions are decision support.
4
CDSS application can also provide diagnosis and treatment recommendations based on clinical information. As in
McCullough et al. (2013) we do not focus on the CDSS application itself due to inconsistent reporting in the HIMSS
data.

8

types of features that provide automatic reminders, check lists, and error checking may be
expected to have direct impacts on preventable adverse events that the patient safety indicators
we examine are intended to measure.
In addition to CPOE, we also provide separate analyses for Physician Documentation.
Physician Documentation allows physicians to input information. It also generates diagnostic
codes from clinical information. These codes can be used both for billing purposes, but also to
enhance communication between practitioners through standard coding (Dranove et al. 2012).
Physician Documentation may be expected to reduce adverse events when care is administered
by multiple practitioners who must communicate efficiently and coordinate a patient‚Äôs care.

2.2. Why Do Hospitals Adopt EMR Technologies?
The primary reasons cited for hospitals to adopt EMR technologies revolve around
healthcare quality and costs. For example, President Obama stated on January 8, 2009 the
following: ‚ÄúTo improve the quality of our health care while lowering its cost, we will make the
immediate investments necessary to ensure that within five years, all of America‚Äôs medical
records are computerized. This will cut waste, eliminate red tape, and reduce the need to repeat
expensive medical tests. But it just won‚Äôt save billions of dollars and thousands of jobs ‚Äì it will
save lives by reducing the deadly but preventable medical errors that pervade our health care
system.‚Äù
Adoption of EMRs can reduce costs for hospitals by eliminating redundancy, as noted by
the President. Further, as noted in Hillestad et al. (2005), EMR adoption can lower costs by
reducing drug, radiology, and laboratory usage, reducing clerical staff, reducing nursing time,
lowering medical errors, and shortening inpatient lengths of stay. Adoption of EMRs can

9

improve healthcare quality by reducing errors and improving disease prevention and chronic
disease management (Hillestad et al., 2005). In addition to these direct benefits to an adopting
hospital, as Wang (2012) notes, EMR adoption may generate externalities, meaning its value to
one hospital depends on the adoption decisions of other hospitals. Specifically, the value of
adopting EMR for a given hospital may increase as a function of the number of other hospitals
with EMR, since information transfer becomes easier as more hospitals participate. However,
the opposite may be true if EMR adoption attracts more patients, such that ultimately the profits
of adoption decrease as the number of adopters increases.
In deciding whether to adopt EMRs, a hospital must balance the above (potential)
benefits against the costs of adopting. The Congressional Budget Office (CBO, 2008) estimates
the cost of EMR adoption for a typical urban hospital to range between $3 and $9 million, along
with between $700,000 and $1.35 million per year for maintenance. The costs and benefits of
adoption certainly change over time, as do awareness levels across hospitals and patients.
Hence, as we discuss in Section 3, there is significant variation in hospitals‚Äô timing of adoption
of EMR technologies. This variation is important for us to identify the health effects of these
technologies, and our econometric methods are designed to account for potential factors that may
concurrently influence EMR adoption and health outcomes, as we discuss in our Methods
section.

2.3. What are Patient Safety Indicators?
Developed by AHRQ, patient safety indicators (PSIs) are intended to measure
preventable in-hospital complications and adverse events. These indicators are well-defined and

10

have gained traction as a health outcome of interest in the general literature on policy
interventions and hospital quality of care (e.g., Iizuka 2013).
Using PSIs as measures of patient outcomes is one important innovation of our study.
PSIs comprise a particularly important set of outcomes for the purpose of identifying the effect
of EMR adoption. These measures have the advantage of being more variable than other health
outcome measures such as mortality, and allow us to examine the effects of EMRs on
meaningful health outcomes that are less severe than mortality. Patient mortality has been
commonly used as a reliable indicator for quality of care, especially for the elderly and severely
sick population. However, being an extreme outcome measure, patient mortality might fail to
capture improvement in health outcomes resulting from EMR adoption if patients most likely to
be impacted by EMRs are not sick enough to experience mortality. As we discuss below, this
might be particularly true for patients most impacted by clinical decision support aspects of EMR
technologies.
In addition to representing a significant indicator of patient well-being, PSIs are linked to
increased healthcare utilization and cost. Zhan and Miller (2003) use the 2000 Nationwide
Inpatient Sample to examine how adverse events measured by patient safety indicators impact
health care utilization and eventual mortality. They use a multivariable matching estimator to
compare length of stay, hospital charges, and in-hospital mortality for patients experiencing an
adverse event to observably similar patients within the same hospital not experiencing an adverse
event. They find statistically significant differences in these three outcomes for all of the PSIs
that we examine in this paper. For example, they find that patients with postoperative pulmonary
embolism or deep vein thrombosis spend 5.36 additional days in the hospital, have higher
hospital charges by $21,709, and have a 6.56% higher in hospital mortality rate. While these

11

differences may be partially driven by unobserved severity, they motivate that PSIs have
important implications for downstream health care utilization and costs, and in addition to
representing decreased patient well-being, can lead to potential increases in mortality.
We focus our analysis on the following four PSIs: postoperative hemorrhage or
hematoma, postoperative physiologic and metabolic derangement rate, postoperative respiratory
failure rate, and postoperative pulmonary embolism or deep vein thrombosis. In presenting our
main results, we aggregate these into a single measure of those experiencing at least one of these
four postoperative adverse events. We make our choice of PSIs based on the opinion of clinical
experts, following the strategy of Parente and McCullough (2009). 5 Particularly, we have chosen
PSIs that are most likely to be impacted by the availability of EMRs, in particular those that
measure adverse events that can be prevented by checklists and reminders and/or by the
provision of the detailed clinical information regarding the patient. We exclude from our analysis
PSIs that occur with extremely low incidence such as deaths in low mortality diagnosis-related
groups.
In addition to examining this set of PSIs that are most likely to be directly linked to
EMRs, we also examine a number of PSIs that measure adverse events tied more directly to
surgical skills and physical accidents. We present results of these PSIs as a falsification test.
Appendix Table 1 provides definitions of all of the PSI outcomes used in our analysis.

2.4. Mechanisms and Possible Heterogeneous Effects of EMR Adoption

5

As mentioned above, one prior study by Parente and McCullough (2009) has analyzed the effect of EMR adoption
on PSIs. The PSIs they utilized were: infection due to medical care, postoperative hemorrhage or hematoma, and
postoperative pulmonary embolism or deep vein thrombosis. We look at a broader list of PSIs; however, due to data
changes, we do not include infection due to medical care.

12

We largely follow McCullough et al. (2013) in discussing two main channels through
which EMRs are expected to impact health outcomes: clinical decision support and information
management/care coordination. Clinical decision support includes a variety of tools that, in
conjunction with patient data, can supply the provider with rules-based protocols, treatment
guidelines, and error checking. Information management and care coordination are related
mechanisms through which EMR technologies can assist providers in monitoring large amounts
of clinical data about their patients and in coordinating treatment between multiple providers.
These mechanisms each lead to different predictions about which types of patients may
benefit most from EMR adoption. McCullough et al. (2013) suggest that decision support may be
most beneficial for moderate to low complexity patients, arguing that ‚ÄúStandard treatment
guidelines are rarely implemented for complex combinations of diagnoses.‚Äù In other words
treatment guidelines, protocols, and reminders are less beneficial when providers must care for
patients with multiple interacting conditions and complexities.
While this may seem counterintuitive, rule based decision making that can be aided by
decision support systems are most effective when a simple rule is available for a well-defined
problem (Musen et al. 2006). The field of bioinformatics continues to struggle with the design
and implementation of decision support systems for patients with multiple comorbidities.
Therapeutic plans and clinical guidelines are typically disease specific without clear
recommendations for handling comorbidities (Jafarpour and Abidi 2013). There is concern that
some decision support systems may in fact present harmful advice if they do not properly
account for comorbidities (Fraccaro et al. 2015). While the field of informatics is making
progress in developing methods for merging clinical guidelines in decision support systems

13

(Jafarpour and Abidi 2013), this area has been identified as a ‚Äúgrand challenge‚Äù in the field of
decision support (Sittig et al. 2008) and remains under investigated (Fraccaro et al. 2015).
Alternatively, information management and care coordination mechanisms are most
likely to play a role in high complexity patients, particularly those with conditions that involve
synthesizing a large amount of clinical information or many different types of providers.
McCullough et al. (2013) find EMRs to have no overall impact on mortality among Medicare
patients, but evidence that EMRs improve mortality for the highest severity patients. They
further decompose these effects and find the largest benefits for patients with conditions most
relevant to information management and care coordination.
While McCullough et al. (2013) do not find empirical evidence for the prediction that
decision support applications have meaningful health effects in less complex cases, our context
may lead to different results since our analysis uses a more diverse patient population and an
outcome measure that is arguably more amenable to a decision support function. With regards to
patient population, older patients on average are likely to have greater complexity, therefore
leading decision support to be a potentially more important mechanism for younger patient
populations. For example, a previous study by Javitt et al. (2008) finds improvements in quality
of care from decision support in an HMO population of patients all less than 65 years of age.
We might also expect different outcomes to respond differentially to these mechanisms.
In particular, patient safety indictors might better capture differences in health outcomes for less
complex cases as compared to mortality. Therefore, by examining these less severe, but
medically meaningful outcomes, we may be able to better detect the effects of decision support
on care quality. For example, decision support may prompt physicians to order anticoagulants in
order to prevent deep vein thrombosis (measured in PSI 12) among surgical patients

14

(McCullough et al. 2013). In addition to patient safety indicators, we also examine alternative
outcomes such as inpatient mortality, which may be a more relevant outcome for higher severity
patients. Comparing the impact of EMRs on patient safety indicators and inpatient mortality
could help shed light on the underlying mechanism, since the former could be relatively more
driven by decision support and the latter relatively more driven by care coordination.
Finally, these mechanisms also point to potential differential effects by type of EMR
technologies. Whereas both technologies we study can contribute to both decision support and
care coordination, they have different primary focuses. CPOE provides a platform by which the
physician directly interacts with the IT system to submit orders, and decision support is often
incorporated into the CPOE interface. In contrast we expect the adoption of Physician
Documentation to be more relevant to the care coordination mechanism through its ability to
allow physicians to clearly document and communicate patient information.

3. Data
3.1. Data Construction
The data we use come from several sources, and to our knowledge, this is the first study
using such integrated data. Our first source of data is the Healthcare Information and
Management Systems Society (HIMSS) Analytics Database. HIMSS conducts an annual survey
of health care providers, including over 3,000 hospitals nationwide with more than 100 beds. The
survey collects a wide range of information on more than 100 different health information
technology applications, including CPOE and Physician Documentation. For each of these

15

applications we construct variables for whether or not a hospital has installed a system in a given
year. 6 The HIMSS data we have span the years from 2003 to 2010.
Our second data source is the Nationwide Inpatient Sample (NIS), collected by the
Agency for Healthcare Research and Quality‚Äôs (AHRQ) Healthcare Cost and Utilization Project
(HCUP). The NIS is a 20-percent, nationally representative, stratified sample of U.S.
community hospitals. Since NIS includes the universe of inpatient discharge records from these
sampled hospitals, we are able to observe both Medicare and non-Medicare insured patients. For
each discharge record, the data set includes information such as diagnosis and procedure codes,
admission and discharge status, patient demographics, expected source of payment, length of
stay, and hospital charges. The NIS also reports basic hospital characteristics including size,
location, ownership type, and number of total discharges.
NIS provides detailed patient data to build measures of Patient Safety Indicators (PSIs),
our main outcomes of interest. We calculate these indicators using a module provided by AHRQ.
This module uses information in the discharge record, such as age, diagnosis related groups,
diagnosis codes, and procedure codes to identify the subpopulation of patients for whom a
particular adverse event is relevant and those who have experienced the adverse event. For
example, for the PSI indicating Postoperative Hemorrhage or Hematoma, the module first
identifies patients who have received operations and might be at potential risk, and then it
determines which of these patients have experienced a hemorrhage or hematoma.
We supplement the HIMSS and NIS data with American Hospital Associate (AHA) data.
The AHA data is used to build a crosswalk between the HIMSS and NIS data. The only external
hospital identifier in the HIMSS data is the hospital‚Äôs Medicare provider numbers. The only

6

Following the guidance from HIMSS, we consider an application as installed if its status in the HIMSS data is live
and operational, automated, to be replaced, or replaced.

16

external hospital identifier in the NIS data is the hospital‚Äôs AHA ID number. AHA data contain
both identification numbers, thus allowing us to merge the HIMSS and NIS data at the hospitalyear level.
Ultimately, our merged sample includes more than 9.1 million patient observations from
a total of 1,896 unique hospitals in 29 states. 7 Table 1 provides a comparison of our sample to
the universe of the hospitals from these 29 states and from all states. Overall our sample is
slightly weighted toward nonprofit, large, teaching hospitals in urban areas, partly due to the NIS
sampling design and the availability of the AHA ID number, but provides a general
representation of US hospitals.

[Table 1 about here]

While the NIS is not a panel of hospitals, a large fraction of hospitals appear in the data
in multiple years. In our final sample spanning from 2003 to 2010, we observe 1,133 unique
hospitals that appear at least twice. 8 This allows us to relate changes in patient safety to changes
in EMR adoption within hospitals and over time. Others have used the fact that hospitals appear
in the NIS in multiple years to exploit within-hospital changes in other contexts (e.g. Kolstad and
Kowalski, 2012).

3.2. Construction of Key Variables

7

Note that AHA identification numbers are only available for hospitals from a subset of states in the NIS, as some
states have not authorized HCUP to release information that would specifically identify hospitals. We observe 3,858
unique hospitals in the 2003 to 2010 NIS data. Of these, 2,377 unique hospitals have AHA identification numbers
available in the data. We are able to merge 1,922 of these hospitals to the HIMSS data.
8
The sample size for each regression described below varies, as the number of patients at potential risk for each PSI
may differ.

17

Our main analysis focuses on an aggregate PSI which equals 1 if a patient experiences
any of the four postoperative adverse events expected to be linked to EMRs (PSI9, PSI10, PSI11,
and PSI12). We are interested in exploring whether EMR adoption has heterogeneous effects
based on patients‚Äô levels of complication. To this end, we use a variety of proxies to measure
various metrics of complications, including case complexity, diagnosis commonality, mortality
risk, and functional severity. To measure complexity, we use information on a patient‚Äôs
comorbidities. We define a less complex patient as one having no more than one comorbidity. To
measure diagnosis commonality, we utilize diagnosis-related group (DRG) information. We
consider a patient with a DRG code among the top 20 most frequent DRGs for each PSI under
study to be more common. To measure risk and severity, we use data available in the NIS
severity files that differentiate patients by their mortality risk and their loss of function. 9
Regarding risk type, we define low mortality risk cases as those with a ‚Äúminor likelihood of
dying‚Äù and high risk cases as those with ‚Äúmoderate‚Äù, ‚Äúmajor‚Äù or ‚Äúextreme likelihood of dying.‚Äù
Regarding severity, we define low severity cases as those with ‚Äúminor loss of function‚Äù and high
severity cases as those with ‚Äúmoderate,‚Äù ‚Äúmajor‚Äù or ‚Äúextreme loss of function.‚Äù
We also consider patient age, which can serve as a proxy for complication along all four
of the above categories. This is because we expect that the non-elderly, on average, present
simpler, more common, less risky and less severe cases. An additional advantage of exploring
heterogeneity by age is that our results can be directly compared to existing studies which have
focused on the elderly population alone through their focus on Medicare data.

9

The two variables names used are APRDRG_Risk_Mortality and APRDRG_Severity. They are assigned using
software developed by 3M Health Information Systems. Their calculation includes the base APR-DRG, the severity
of illness subclass, and the risk of mortality subclass within each base APR-DRG. For more information, please
refer to the HCUP User Support Website (www.hcup-us.ahrq.gov).

18

3.3. Summary Statistics
Table 2 shows the fraction of hospitals in our analysis sample that have adopted CPOE
and Physician Documentation by year. CPOE adoption rates grew from 7% to 31% from 2003 to
2010. Physician Documentation grew from 18% to 39% from 2005 to 2010. 10 This rapid
diffusion provides the key variation we use to identify the effect of EMR adoption on patient
safety.

[Table 2 about here]

Table 3 presents summary statistics of our PSI measures. For each PSI used in our
analysis, a value of 1 indicates a patient experiencing an adverse event. Note that sample size
varies across PSIs because the set of patients that are potentially at risk of each adverse event is
different. In Table 3, we present the mean value of each PSI, which indicates the average rate of
occurrence among its relevant population. For example, for Agg PSI, the aggregate PSI, we
observe an average of 1.81% with a standard deviation of 13.31%. In our sample, with a total of
9.1 million patients at potential risk, it suggests that about 165,000 patients had experienced at
least one of the adverse events.

[Table 3 about here]

10

Note that Physician Documentation was first added to HIMSS in 2005. We are able to uncover the status of
adoption in 2003 and 2004 for non-adopters (those that did not adopt between 2005 and 2011) and late-adopters
(those that adopted between 2005 and 2011). For those that we observe adoption in 2005, we are not able to tell the
year of adoption so we do not fill in these missing values.

19

Table 4 provides summary statistics of the aggregate PSI by patient complication. Not
surprisingly, we find that the rate of occurrence of adverse events is lower for less ‚Äúcomplicated‚Äù
patients; however, PSIs are still meaningful health outcomes for less complicated patients as
defined by most of our proxies. For example, nonelderly patients have a mean of 1.49% while
elderly patients have a mean of 2.21%. Similarly, the mean is 0.53% for low-mortality-risk
patients but as high as 4.02% for high-mortality-risk patients. We also explore how our measures
of complication overlap with each other. We find that among the ten correlation coefficients
between these measures, eight are smaller than 0.25. The remaining two are 0.36 (between low
mortality and common DRG) and 0.49 (between low mortality and low severity). These numbers
suggest that our measures for case complication seem to provide meaningful variation along
different dimensions.

[Table 4 about here]

4. Empirical Model
Our general empirical strategy for testing the impact of EMR adoption is to relate withinhospital changes in patient safety over time to within-hospital changes in the availability of
EMRs. Hospitals that do and do not have EMRs may be very different from each other.
Therefore it is important to exploit over time variation in EMR adoption. The key identifying
assumption is that trends in the prevalence of PSIs are not correlated with unobserved adoption
trends. In other words, our empirical strategy hinges on the idea that when a hospital adopts
EMRs there are no concurrent events, left unaddressed by our controls, that would have an
impact on patient safety. If this assumption is satisfied, we can attribute changes in patient safety

20

to EMR adoption. McCullough et al. (2013) and Agha (2014) provide extensive evidence that
EMR adoption is unlikely to be correlated with pre-existing trends in patient outcomes or
severity in the Medicare context. In results shown below we perform a variety of tests to ensure
this assumption is likely to hold in our empirical context as well.
Our baseline empirical specification follows a linear probability model, with hospital and
time fixed effects:
ùëÉùëÜùêºùëñ‚Ñéùë° = ùõΩ0 + ùõøùë° + ùõº‚Ñé + ùëçùëñ‚Ñéùë° ùõΩ1 + ùõΩ2 ùê∏ùëÄùëÖ‚Ñéùë° + ùõΩ3 ùê∏ùëÄùëÖ‚Ñéùë° ‚àó ùëãùëñ‚Ñéùë° + ùëãùëñ‚Ñéùë° ùõΩ4 + ùëãùëñ‚Ñéùë° ‚àó ùêº_ùë¶ùëíùëéùëü + ùúÄùëñ‚Ñéùë°
PSIiht represents the occurrence of an adverse event for patient i in hospital h during year t. ùõº‚Ñé is

a set of hospital fixed effects, ùõøùë° is a set of year fixed effects, and ùëçùëñ‚Ñéùë° stands for a set of patient-

level control variables, including age, age squared, gender, race dummies, payment dummies,

risk dummies, severity dummies, and 27 different comorbidity dummies as defined by AHRQ. 11
EMRht is a dummy variable for the presence of an EMR system installed in hospital h at year t. 12
ùëãùëñ‚Ñéùë° is one of the following dummies to represent patient heterogeneity: non-elderly, non-

complex, common DRG, low-mortality risk, and non-severe case. We interact each dummy
variable (ùëãùëñ‚Ñéùë° ) with the EMRht dummy to allow the effect of EMR to differ on the basis of patient
heterogeneity. We also include group specific year fixed effects (ùëãùëñ‚Ñéùë° ‚àó ùêº_ùë¶ùëíùëéùëü) to allow
outcomes to differ arbitrarily between each group over time.

We are particularly interested in the estimates of ùõΩ2 , which measures the overall effect of

EMR adoption, and ùõΩ3 , which measures whether the effect varies by patient complication level.

In addition, ùõΩ4 measures whether patient safety indicators vary based on patient complication
level itself. The estimation of the model uses discharge weighting and standard errors are

11

All of our results hold if we include some hospital level controls such as hospital bed size, urban vs. rural location,
and ownership type.
12
Adding additional controls such as state-year fixed effects and differential trends based on hospital characteristics
such as teaching status produce largely similar results. See more discussion in Section 5.2 where we address
endogeneity concerns.

21

clustered at the hospital level. 13 We provide separate analyses for CPOE and Physician
Documentation. Note that the results of the effect of each application do not change if we
analyze both EMRs jointly within the same regression.
We also extend our baseline model in a number of ways. First, we explore how the
impact of EMR adoption on patient safety differs by time since adoption. For this analysis we
replace the EMR dummy with three different dummies indicating the first, second, or third or
more year of adoption. This specification allows for the fact that it may take time to fully and
optimally incorporate EMR usage into practice patterns. Coefficient estimates from this
specification reveal how this process evolves from the first year of adoption through later years.
Second, in related specifications, we include dummies for years prior to adoption to test the
identifying assumption that adopting hospitals do not have differing pre-adoption patient safety
trends. Last, we further explore heterogeneity by examining a three-way interaction of EMR
application, non-elderly and non-complicated case. Our baseline model differentiates patients
along a single dimension of heterogeneity. This extended model allows for an additional
interaction between age and level of complication to test if the effect of EMRs differs by
complication within age groups.

5. Results
5.1. Main Results
We first report our main results for CPOE in Table 5. Note that for ease of presentation,
we multiply all coefficients and standard errors by 100. We find an overall negative but
statistically insignificant effect of CPOE on the probability of experiencing an adverse event.

13

Weights are provided in the NIS data and are intended to produce nationally representative estimates, accounting
for the sampling frame.

22

Allowing for heterogeneous effects by patient age (column 1), we find that CPOE has a larger
effect on non-elderly patients, suggesting that non-elderly patients are likely to benefit more
from CPOE adoption. We also observe consistent patterns of results when examining
heterogeneous effects along other dimensions. We find that complicated cases are not affected by
CPOE; however, non-complicated cases do experience large decreases in PSI occurrences. All
interaction effects are large in magnitude and statistically significant. The F-statistics reported in
this table allow us to reject the hypothesis that the overall effects for less complicated patients
(main effects of CPOE plus interaction effects) are equal to zero. To be more specific, the
adoption of CPOE is associated with a 12% ((0.016-0.180)/1.34) drop in the probability of
experiencing at least one postoperative adverse event for cases with no more than one
comorbidity (non-complex). We find no significant effect of CPOE on patients with less
common DRGs; however, patients that are diagnosed with more common DRGs experience a
20% ((-0.14-0.033)/0.86) decrease in the probability of an adverse event with the adoption of
CPOE. Similarly we find a largely lowered rate of adverse events for patients with low mortality
risk and low severity. 14

[Table 5 about here]

The pattern of estimates observed in Table 5 suggests the importance of allowing for
heterogeneity when examining the effect of CPOE adoption. Since these measures of case

14

The percentage declines for these last two measures are 43% and 135%, respectively. We acknowledge that these
percentage figures are high, and likely due to the fact that these two events have particularly low means and we are
using a linear probability model (which does not force probabilities to be above zero). We have attempted to run
these two models in particular using a logit framework; however, they do not converge due to the very large number
of fixed effects. Nevertheless, we note that these results, while quantitatively high in percentage terms, qualitatively
line up with our results for the other higher-probability events we analyze.

23

complication provide variation along different dimensions, finding qualitatively consistent
results among them also suggests that CPOE is more likely to improve patient outcomes for less
complicated cases through the clinical decision support mechanism.
To get a sense of how these improvements in PSIs translate to reduction in healthcare
costs, we conduct a back-of-envelop calculation using data from Zhan and Miller (2003). For
example, Zhan and Miller (2003) find that patients that have experienced postoperative
respiratory failure are associated with an excess charge of $74,052 in 2014dollars. They also
provide the amount of excess charge for the other three PSIs used in our study. Since we focus
on the aggregate PSI, we calculate the average excess charge across the four PSIs, which
amounts to $52,409 in 2014 dollars. Zhan and Miller (2003) also find that these PSIs increase
hospital stays by 6.81 days on average. According to the NIS 2010 data, a total of about 8.1
million patients nationally were at potential risk of experiencing any of the four postoperative
adverse events. Of this 8.1 million, 3.89 million, 2.43 million, 4.94 million, and 2.84 million are
of low-complexity, common DRG, low-mortality risk, and low severity respectively. Our results
suggest that CPOE decreases the probability of such adverse events by 0.164 percentage points
for non-complex patient (Column 2 of Table 5), translating to 6,376 prevented adverse events per
year based on the number of low-complexity patients in the 2010 NIS. This amounts to a total of
more than $334 million in hospital charges (or 43,423 inpatient days) for those affected noncomplicated cases in 2010. Depending on the model specification that we use, these figures
range from savings of $220 million (or 28,629 inpatient days) if we focus on common-DRG
cases to about $590 million (or 76,717 inpatient days) for low-mortality cases. These
calculations suggest that CPOE is associated with a large decrease in hospital charges and
inpatient length of stays. Note that since our main outcome variables are relevant for a subgroup

24

of the patient population, those numbers represent part of the potential savings associated with
EMRs.
We report the same set of results for Physician Documentation in Table 6. We find less
pronounced effects for Physician Documentation, although the pattern of heterogeneous effects
is similar to the findings for CPOE. Physician Documentation is found to significantly reduce
the occurrence of adverse events only for patients with low mortality risk (column 4). As
indicated in Section 2, there is reason to believe CPOE and Physician Documentation may have
differing impacts on health outcomes, since the former has more capability toward clinical
decision support and the latter toward care coordination.
It is important to note that for all the analyses reported in the paper, combining CPOE
and Physician Documentation in the same regression provides similar results. For the remainder
of the paper, we focus our analysis on CPOE, since it is the EMR, of the two, that appears to
display a notable impact on PSIs. 15

[Table 6 about here]

5.2. Endogeneity Concerns
In this section, we first discuss and address potential endogeneity issues resulting from
unobserved heterogeneity between adopting and non-adopting hospitals. We then explore
whether patient composition changes following the adoption of EMRs, which might also cause
bias in our estimation.

15

The full set of results with both CPOE and Physician Documentation in the same regressions are available upon
request.

25

The fact that hospitals actively decide to adopt CPOE or any type of EMR applications
poses concerns about potential bias. In our main specification, we use hospital fixed effects to
account for the fact that adopting and non-adopting hospitals may differ in terms of baseline
characteristics. Therefore, our key identifying assumption is that hospitals that adopt during our
sample period do not exhibit differential trends in unobserved factors that might impact changes
in PSI prevalence over time. However, there might be cases in which our assumption is not valid.
For example, adopting hospitals might have been simultaneously implementing other quality
initiatives to improve quality of care. If this is the case, our identification would be
contaminated, as we could not differentiate whether the estimated improvement in patient
outcomes is driven by CPOE or by other quality initiatives.
To address these endogeneity concerns, we adopt three strategies. First, it is the case that
adopting hospitals differ from non-adopting hospitals along important observable dimensions
such as ownership type, size, and teaching status. While our hospital fixed effects take into
account any time invariant differences between these types of hospitals, these hospitals might
follow differing trends over time in both patient safety and EMR adoption. To take this into
account, we have expanded our baseline model by allowing for differential trends based on
teaching hospital status, ownership, and hospital size, and we find largely similar results. Our
main findings are also robust to the inclusion of state-year fixed effects. 16
Second, we run our model on a set of PSIs that are not likely to be affected by EMRs
because they are mostly the result of physician skills or physical accidents. For this set of PSIs,
we should not expect to find any significant effect for EMRs unless our results are driven by
other quality initiatives that have been implemented simultaneously with EMR adoption. These
results are reported in Table 7 for PSI6, PSI7, PSI8 and PSI15. For each of these PSIs, we find
16

These results are available from the authors upon request.

26

very small and not statistically significant effects of CPOE, regardless of patient type. While
some of the interaction terms are statistically significant, the overall effect of CPOE on each PSI
for the less complicated groups are not statistically significant when considering the combination
of the main effects and the interaction effects. It is not likely that quality initiatives would work
exactly like EMRs (namely being related to our affected PSIs and not related to our unaffected
PSIs). Passing these falsification tests suggests that our results are not likely driven by other
quality initiatives implemented in the adopting hospitals. Note that for this falsification test, the
sample is restricted to the population at potential risk for the PSIs in our main analysis (PSI9 to
PSI12) so that these results are directly comparable to our main findings. Expanding the sample
to all patients at risk for these placebo PSIs leads to very similar results.

[Table 7 about here]

Our third strategy for testing the parallel trends assumption is to estimate a model with
the inclusion of adopting lead dummies. We define one indicator variable for being one or two
years prior to adoption and one for being three or four years prior to adoption. 17 The coefficients
in front of these two dummies capture whether there is any differential trend in PSI prevalence
between adopting and non-adopting hospitals in the years prior to the adoption actually
occurring. Column 0 of Table 8 shows that when we consider all patients together, there are no
changes in PSI prevalence prior to CPOE adoption. In the subsequent columns we find no
statistically significant differential pre-trends for either complicated or non-complicated cases,

17

These are constructed by merging HIMSS adoption data from previous years to the years that we observe a
hospital in the NIS data. Note that the sample size for this set of regressions is smaller since, for hospitals that have
adopted CPOE prior to 2003, we are not able to track down the exact year of adoption. This applies to our following
analyses of the differential effects by years since adoption too (Table 10).

27

regardless of our measure of complication. Results from F-tests all fail to reject that there is any
significant effect of these lead dummies on less-complicated cases when considering all four
years prior to adoption together. Similar to our main findings, the contemporaneous effects
suggest that less complicated cases see improvements in PSI prevalence after CPOE is adopted.

[Table 8 about here]

One remaining concern is that the adoption of EMRs might be related to changes in
patient composition. For example, EMR adoption may cause a different set of patients to be
attracted to the adopting hospital. In addition, our results would be erroneous if EMR adoption
affects the margin of patients assigned to high or low levels of complication due to changes in
coding. To address these issues, we specifically explore whether patient composition changes
after EMR adoption. We proceed by aggregating our data to the hospital-year level by averaging
measures of patient composition, such as age, race, insurance status, and indicators for case
complication. We then regress these measures on the adoption of CPOE and Physician
Documentation, controlling for time and hospital fixed effects. The results are reported in Table
9. While we find a significant effect of Physician Documentation on the fraction of white
patients, all the remaining coefficients are small and not statistically significant. We also find no
evidence that EMR adoption is associated with changes in our measures of complication, with
the lone exception being a small correlation between the fraction of less complex patients and
Physician Documentation. Overall, we find there are no systematic changes in patient observed
characteristics and patient case complication coinciding with EMR adoption, which reassures us
of the validity of our identification assumption.

28

[Table 9 about here]

5.3. Timing of Effect
We also explore heterogeneity by time of EMR adoption. The adoption of a new EMR
system may not immediately improve health outcomes. Healthcare providers, such as physicians,
nurses, and other staff, must be trained to use new systems. It may take additional time for
providers to learn how to use the new systems to optimally impact patient‚Äôs health. 18 In this
sense, we might see some delay in observing quality improvement. On the other hand, hospitals
might have taken these delays into consideration when adopting an EMR. For example,
employees might have been trained so that they can take advantage of the EMRs once these
applications are installed and put to use.
Examining the timing of effect also mitigates a limitation of our data. Because the NIS is
not a true panel, our baseline model treats hospitals that have adopted EMRs between
observation years the same, regardless of which year they actually adopted the technology. By
utilizing the HIMSS data to calculate the number of years an application has been installed, we
can more precisely differentiate the relationship between actual adoption year and changes in
patient safety.
Table 10 presents estimates separating the effect of adoption by the number of years
CPOE has been put in use. While many of the coefficient estimates themselves are not
statistically significant, when we combine the main effects and the low complication interactions,
we find CPOE has a consistent impact on patient safety over time for less complicated cases. The

18

Dranove et al. (2012) find that cost savings from EMRs in IT-intensive do not occur immediately and instead
materialize 3 years after a system is put in place.

29

F-statistics for these combined effects are presented at the bottom of the table. For example,
CPOE decreases non-complex patients‚Äô probability of experiencing at least one postoperative
adverse event by 0.203 (15.1%) and 0.197 (14.7%) percentage points in years one and two,
respectively. Having CPOE installed for three or more years lowers the chance of patients
experiencing at least one adverse postoperative event by 0.222 (16.6%) percentage points. These
results suggest that the effect of CPOE takes place beginning the first year of use and the effect
persists over time.
[Table 10 about here]

5.4. Additional Levels of Heterogeneity
In addition to exploring differential effects of CPOE along various metrics of patient
complication, we also estimate an extended model to allow these effects to vary by age group
(elderly vs non-elderly) and case complication. These results are reported in Table 11. The first
column replicates previous results of the heterogeneous effect by age group. In column 2, we
also include an interaction between CPOE and a dummy for a non-complex case, and a three
way interactions between CPOE, non-elderly and non-complex case. The results suggest that the
largest decrease in occurrence of adverse events is realized for non-elderly and non-complex
cases. In the remaining columns, we also explore commonality of DRG (column 3), mortality
risk (column 4), and severity (column 5). We find consistent results that CPOE has the largest
impact for non-elderly and non-complicated patients. In addition, we also see some improvement
in patient outcomes for elderly but non-complicated cases.
By introducing two dimensions of complication (age and case complication), we find the
largest effects for patients in the least complicated category when both dimensions are combined.

30

These results provide additional evidence the CPOE is likely to impact patient outcome through
the channels that would have the largest impact on the least complicated cases, further
suggesting clinical decision support as the most likely mechanism.

[Table 11 about here]

5.5. Two Alternative Outcomes
In addition to PSIs, we also present results using two alternative outcomes: inpatient
mortality and length of stay. Mortality has been commonly used in the existing studies
examining the impact of EMRs. Previously, we argued one concern about using mortality is that
it is considered as an extreme outcome, so it might fail to capture improvement in patient
outcomes that are not directly tied to patient death, especially for the decision support aspect of
EMRs which tends to have a larger impact on less complicated cases. However, one could also
argue that patient mortality might be a more relevant measure of outcome for the care
coordination aspect of EMRs since the likely affected patients through this mechanism might be
severely sick and at potential risk of mortality. To address this concern, we provide additional
analyses using inpatient mortality as the outcome. In our data, we observe when a patient dies
during their hospital stay; although, the results have to be taken cautiously as inpatient mortality
does not capture death that occurs during a readmission or outside of the hospital.
The results for inpatient mortality are reported in Table 12. Consistent with previous
findings, we find no effect of CPOE on inpatient mortality, regardless of patient characteristics. 19
In results that we do not report here, we also find no effect of Physician Documentation on
19

The mean mortality rate is 0.017 with a standard deviation of 0.128 in the data. We also estimate an extended
model to allow three-way interaction terms for CPOE, non-elderly and dummies for complication. We find
consistent results that there is no effect of CPOE on patient mortality.

31

inpatient mortality. These findings provide additional support for our main findings that clinical
decision support is likely the main mechanism through which EMRs impact patient outcomes in
our study.
The other outcome we examine is patient length of stay (logarithm), and the results are
also reported in Table 12. 20 Interestingly, we find a large decrease in length of stay (LOS) for
non-complicated cases, consistent with our main findings that CPOE lowers the probability of
adverse events, which themselves are likely to increase length of stay for those patients. For
example, we find that CPOE lowers patient LOS by 1.2% for low mortality risk patients and
2.10% for low severity patients. We do not find statistically significant effects for complicated
cases. Finding a positive effect for LOS and no effect for inpatient mortality among the same set
of patients highlights the importance of using a less extreme outcome measure in capturing
improvement in quality of care for less complicated cases.

[Table 12 about here]

6. Conclusion
By combining the Healthcare Information and Management Systems Society Analytics
Database with the National Inpatient Sample, we test how adoption of advanced electronic
medical records (CPOE and Physician Documentation) affects the incidence of patient safety
indicators, and whether this effect differs across case complication. We find that CPOE
decreases the prevalence of patient safety indicators that are likely to be amenable to decision

20

In addition to providing evidence using an alternative outcome measure, length of stay has the advantage of being
a continuous variable. Finding consistent results provides reassurance concerning the use of a linear probability
model for modeling our discrete dependent variables ‚Äì PSIs.

32

support functions, particularly for less complicated patients. We find little impact of Physician
Documentation on these quality measures. Taken together, the fact that we find the most
consistent benefits of EMR adoption when examining a technology with decision support
features, outcomes likely to be sensitive to decision support, and patient populations for whom
decision support is likely to be most beneficial, our results point to decision support as the most
likely mechanism driving our results.
Our findings have important implications concerning the impact of EMR adoption on
health outcomes. In contrast to previous large-scale studies that focus on Medicare populations,
our findings suggest that younger populations may in fact be currently receiving larger benefits
from EMR adoption. Our results regarding decision support complement McCullough et al.
(2013)‚Äôs findings that care coordination mechanisms improve mortality rates for high severity
Medicare patients with diagnoses specifically necessitating information management and care
coordination. Taken together these studies suggest that different mechanisms can improve care
along different metrics of quality for different patient populations.
The fact that we do not find evidence of care coordination playing a large role for the
broad patient population in our study suggests that the impact of care coordination via EMRs
might be currently limited to a relatively small group of patients. Such lack of evidence also
suggests that further improvement in the interoperability of EMR systems and improved ability
to take advantage of large amounts of data provided by EMR systems are necessary to reap their
full benefits. Note that one caveat of this finding is that the outcome measures we use might fail
to capture improvements in patient outcomes through care coordination. Finer data might also be
needed to identify the set of patients that are more likely to be affected through this mechanism.

33

Our findings also contribute to the discussion of how to push EMR technologies forward
by shedding light on which mechanisms are currently leading to health improvements and which
patient subpopulations are most likely to be affected. While we find that decision support tools
are leading to improved outcomes, further research is warranted to examine the care coordination
aspects of EMRs and understand how providers can better make use of such aspects.

34

REFERENCES
Agha, L. 2014. The Effects of Health Information Technology on the Costs and Quality of
Medical Care. Journal of Health Economics 34: 19 -30.
Autor, D., Levy, L. F., Murnane, R. 2003. The Skill Content of Recent Technological Change:
An Empirical Exploration. Quarterly Journal of Economics 118 (4), 1279-1333.
Autor, D., Levy, F., Murnane, R. 2002. Upstairs, Downstairs: Computers and Skills on Two
Floors of a Large Bank. Industrial and Labor Relations Review 55 (3), 432-447.
Athey, S., and Stern, S. 2002. The Impact of Information Technology on Emergency Health Care
Outcomes. Rand Journal of Economics 33: 399-432.
Baker, G., and Hubbard, T. 2003. Make Versus Buy in Trucking: Asset Ownership, Job Design,
and Information. American Economic Review 93, 551-572.
Bates, D., Leape, L., Cullen, D., Laird, N., Petersen, L., Teich, J., Burdick, E., Hickey, M.,
Kleefield, S., Shea, B., Vliet, M., and Seger, D. 1998. Effect of Computerized Physician Order
Entry and a Team Intervention on Prevention of Serious Medication Errors. Journal of the
American Medical Association 280: 1311-1316.
Bates, D., Teich, J., Lee, J., Seger, D., Kuperman, G., Ma‚ÄôLuf, N., Boyle, D., and Leape, L.
1999. The Impact of Computerized Physician Order Entry on Medication Error Prevention.
Journal of the American Medical Informatics Association 6: 313-321.
Bloom, N., Garicano, L., Sadun, R., and Van Reenan, J. 2014. The Distinct Effects of
Information Technology and Communication Technology on Firm Organization. Management
Science 60: 2859-2885.
Chaudhry, B., Wang, J., Wu, S., Maglione, M., Mojlca, W., Roth, E., Morton, S. and Shekelle, P.
2006. Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and
Costs of Medical Care. Annals of Internal Medicine 144: 742-752.
Congressional Budget Office. 2008. Evidences on the Costs and Benefits of Healthcare
Information Technology. http://www.cbo.gov/ftpdocs/91xx/doc9168/maintext.3.1.shtml.
Accessed on January 16, 2013.
Dranove, D., Forman, C., Goldfarb, A., and Greenstein, S. 2012. The Trillion Dollar
Conundrum: Complementarities and Health Information Technology. NBER Working paper.
Fraccaro, P., Arguello Casteleiro, M., Ainsworth, J., and Buchan, I. 2015. Adoption of Clinical
Decision Support in Multimorbidity: A Systematic Review. JMIR Medical Informatics 3(1), e4.

35

Hillestad, R., Bigelow, J., Bower, A., Girosi, F., Meili, R., Scoville, R., and Taylor, R. 2005. Can
Electronic Medical Record Systems Transform Health Care? Potential Health Benefits, Savings,
and Costs. Health Affairs 24: 1103-1117.
Hubbard, T. 2003. Information, Decisions, and Productivity: On-Board Computers and Capacity
Utilization in Trucking. American Economic Review 93 (4), 1328‚Äì1353.
Iizuka, T. 2013. Does Higher Malpractice Pressure Deter Medical Errors? Journal of Law and
Economics 56: 161-188.
Jafarpour B, Abidi S. 2013. Merging disease-specific clinical guidelines to handle comorbidities
in a clinical decision support setting. Artificial Intelligence in Medicine 7885:28-32.
Javitt, J. Rebitzer, J. and Reisman, L. 2008. Information Technology and Medical Missteps:
Evidence from a Randomized Trial, Journal of Health Economics 27(23):585-602.
Kolstad, J. and Kowalski, A. 2012. The Impact of Health Care Reform on Hospital and
Preventative Care: Evidence from Massachusetts. Journal of Public Economics 96: 909-929.
McCullough, J., Casey, M., Moscovice, I., and Prasad, S. 2010. The Effect of Health Information
Technology on Quality in U.S. Hospitals. Health Affairs 29: 647-654.
McCullough, J., Parente, S., and Town, R. 2013. Health Information Technology and Patient
Outcomes: The Role of Organizational and Informational Complementarities. NBER working
paper.
Miller, A. and Tucker, C. 2011. Can Health Information Technology Save Babies? Journal of
Political Economy 119: 289-324.
Musen, Mark A., Shahar, Y., and Shortliffe, Edward H. 2006. Clinical Decision-Support
Systems in Biomedical Informatics: Computer Applications in Health Care and Biomedicine, 3rd
edition, ed Edward H. Shortliffe and James J. Cimino. Springer
Parente, S. and McCullough, J. 2009. Health Information Technology and Patient Safety:
Evidence from Panel Data. Health Affairs 28: 357-360.
Sidorov, J. 2006. It Ain‚Äôt Necessarily So: The Electronic Health Record and the Unlikely
Prospect of Reducing Health Care Costs. Health Affairs 25: 1079-1085.
Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, et al. 2008. Grand challenges
in clinical decision support. Journal of Biomedical Informatics 41(2):387-392.
Simeonova, E. and Koulayev, S. 2013. Do Electronic Medical Records Improve Patient
Outcomes? Working Paper

36

Wang, S., Bardon, C., Kittler, A., and Sussman, A. 2003. A Cost-Benefit Analysis of Electronic
Medical Records in Primary Care. The American Journal of Medicine 114: 397-403.
Wang, Y. 2012. Cooperation and Competition: The Multilevel Adoption of Electronic Medical
Records in U.S. Hospitals. Working paper, Boston University.
Zhan, C. and Miller, M. 2003. Excess Length of Stay, Charges, and Mortality Attributable to
Medical Injuries During Hospitalization. Journal of the American Medical Association 290:
1868-1874.

37

Table 1: Comparison of Hospitals in Analysis Sample to All Hospitals, 2005

For-Profit
Nonprofit
Bed Size
Teaching
Urban
Inpatient Days
%Medicare
%Medicaid
N

Hospitals in
Analysis
Sample

AHA Hospitals in 29
States for which NIS
includes Hospital IDs

Universe of
Hospitals in AHA
Data

.154
(.361)
.697
(.460)
201.487
(193.275)
.088
(.283)
.454
(.498)
40.364
(55.136)
.597
(.262)
.174
(.693)
1,896

.144
(.351)
.673
(.469)
179.703
(186.542)
.075
(.263)
.415
(.493)
33.000
(48.436)
.624
(.379)
.164
(.572)
2,795

.160
(.367)
.601
(.490)
163.845
(179.641)
.062
(.241)
.421
(.494)
32.301
(48.616)
.618
(.330)
.150
(.449)
4,720

Note: Standard deviations are reported in parentheses. Inpatient days is
measured in 1,000 days. Sample size for Inpatient days, %Medicare, and
%Medicaid is smaller due to missing data.

.

38

Table 2: EMR Adoption by Year
Year

CPOE

Physician Documentation

2003

0.070

-

2004

0.090

-

2005

0.165

0.182

2006

0.175

0.211

2007

0.198

0.234

2008

0.268

0.288

2009

0.304

0.391

2010

0.313

0.386

Note: This table reports the fraction of
hospitals with CPOE and Physician
Documentation installed by year. The sample
includes all hospitals for which we have at least
two observations in the merged HIMSS and
NIS data.

39

Table 3: Summary Statistics of Patient Safety Indicators
PSI 9
Mean (%)
S. D. (%)
N(Million)

0.27
5.19
9.06

Postoperative PSIs
PSI 10
PSI 11
PSI 12
0.12
3.51
4.24

1.04
10.17
3.38

1.15
10.65
9.08

Agg PSI

PSI 6

Control PSIs
PSI 7
PSI 8

PSI 15

1.81
13.31
9.10

0.08
2.81
8.18

0.27
5.14
5.57

1.04
10.15
8.51

0.02
1.43
5.86

Note: This table presents summary statistics of each PSI measure. The unit of observation is at the patient level.

40

Table 4: Summary Statistics for Aggregate PSI by Patient Complication
Case Complication
Mean (%)
S. D. (%)
N(Million)

non-elderly
Yes
1.49
12.13
5.19

No
2.21
14.72
3.91

non-complex
Yes
1.34
11.49
4.94

No
2.36
15.17
4.16

common DRG
Yes
0.86
9.23
3.04

No
2.28
14.92
6.05

low mortality
Yes
0.53
7.23
5.72

No
4.02
19.65
3.29

low severity
Yes
0.22
4.66
3.52

No
2.82
16.55
5.49

Note: This table presents summary statistics of the aggregate PSI, measuring the occurrence of at least one of the postoperative
PSIs, by categories of patient complication. The unit of observation is at the patient level.

41

Table 5: Effect of CPOE on Patient Safety
CPOE
CPOE*X
F-stat of:
CPOE+CPOE*X=0
X= 1 if‚Ä¶

(0)

(1)

(2)

(3)

(4)

(5)

-.080
(.080)

-.036
(.082)
-.077*
(.041)

.016
(.077)
-.180***
(.043)

-.033
(.084)
-.140***
(.045)

.174*
(.097)
-.402***
(.099)

.055
(.080)
-.352***
(.079)

1.84

3.47*

4.75**

6.32**

8.70***

NonElderly

NonComplex

CommonDrg

LowMortality

Non-Severe

Note: Coefficient estimates are from separate fixed effect linear probability regressions of the
aggregate PSIs on dummies indicating adoption of CPOE and its interaction with different measures
for patient complication (ùëã). All regressions control for hospital fixed effects, year fixed effects,
patient characteristics, ùëã, a group specific year fixed effects (ùëã ‚àó ùêº_ùë¶ùëíùëéùëü). All standard errors are
clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

42

Table 6: Effect of Physician Documentation on Patient Safety
PhysDoc
PhysDoc*X
Fstat of:
PhysDoc+PhysDoc*X=0
X= 1 if‚Ä¶

(0)

(1)

(2)

(3)

(4)

(5)

-.002
(.032)

.001
(.041)
-.011
(.040)

.015
(.041)
-.069
(.045)

-.033
(.037)
-.054
(.043)

.118
(.073)
-.200**
(.095)

.042
(.046)
-.122*
(.074)

0.08

0.87

0.95

3.69**

2.43

NonElderly

NonComplex

CommonDrg

LowMortality

NonSevere

Note: Coefficient estimates are from separate fixed effect linear probability regressions of the aggregate
PSIs on dummies indicating adoption of Physician Documentation and its interaction with different
measures for patient complication (ùëã). All regressions control for hospital fixed effects, year fixed effects,
patient characteristics, ùëã, a group specific year fixed effects (ùëã ‚àó ùêº_ùë¶ùëíùëéùëü). All standard errors are
clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

43

Table 7: Falsification Test on Non-affected PSIs
Panel: PS6
CPOE

(0)

(1)

(2)

(3)

(4)

(5)

.003
(.005)

.001
(.006)
.003
(.005)

0.001
(0.006)
0.002
(.005)

.003
(.005)
-.004
(.005)

.013
(.008)
-.016*
(.009)

.008
(.006)
-.012**
(.006)

0.68

0.60

0.04

0.32

0.88

-.004
(.013)
-.002
(.013)

.010
(.017)
-.028**
(.011)

.000
(.016)
-.011
(.013)

.005
(.027)
-.015
(.049)

.002
(.017)
.018
(.017)

0.13

1.29

0.64

0.49

1.08

.000
(.004)
-.003
(.003)

.000
(.003)
-.005*
(.003)

-.002
(.003)
.000
(.003)

-.003
(.005)
.001
(.004)

-.003
(.003)
.002
(.003)

1.55

2.79*

0.45

0.59

0.15

.017
(.031)
-.054**
(.024)

.012
(.022)
-.050**
(.022)

-.014
(.031)
-.020
(.037)

.014
(.036)
-.045
(.051)

.008
(.032)
-.058**
(.028)

1.39

1.38

0.77

0.99

2.44

NonElderly

NonComplex

CommonDrg

LowMortality

NonSevere

CPOE*X
F-stat of:
CPOE+CPOE*X=0
Panel: PS7
CPOE

-.005
(.015)

CPOE*X
F-stat of:
CPOE+CPOE*X=0
Panel: PS8
CPOE

-.002
(-.003)

CPOE*X
F-stat of:
CPOE+CPOE*X=0
Panel: PS15
CPOE
CPOE*X
F-stat of:
CPOE+CPOE*X=0
X= 1 if ‚Ä¶

-.014
(.029)

Note: Coefficient estimates are from separate fixed effect linear probability
regressions of a set of non-affected PSIs on dummies indicating adoption of CPOE
and its interaction with different measures for patient complication (X). All
regressions control for hospital fixed effects, year fixed effects, patient
characteristics, X, a group specific year fixed effects (X ‚àó I_year). All standard errors
are clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

44

Table 8: Lead Effect of Adoption

CPOE
1 or 2 years prior
3 or 4 years prior
CPOE*X
1 or 2 years prior
*X
3 or 4 years prior
*X
F-stat of:
CPOE+CPOE*X=0
1/2 year lead + 1/2
year lead*X=0
3/4 year lead + 3/4
year lead*X=0
X= 1 if‚Ä¶

(0)

(1)

(2)

(3)

(4)

(5)

-.085
(.093)
-.023
(.048)
.013
(.065)

-.040
(.096)
-.015
(.065)
.021
(.084)
-.081**
(.041)

.008
(.091)
-.009
(.061)
.021
(.080)
-.178***
(.044)

-.035
(.098)
-.018
(.055)
.037
(.070)
-.147***
(.047)

.188*
(.111)
.042
(.115)
.042
(.115)
-.435***
(.101)

.056
(.095)
-.002
(.076)
.059
(.077)
-.371***
(.078)

-.016

-.028

-.006

-.101

-.055

(.064)

(.053)

(.041)

(.149)

(.122)

-.015

.063

-.066

-.191

-.110

(.055)

(.048)

(.057)

(.128)

(.104)

1.63

2.89*

4.10**

6.00**

8.55***

0.36

0.53

0.28

0.84

0.54

0.01

0.39

NonElderly

NonComplex

0.17
CommonDrg

0.80
LowMortality

0.83
NonSevere

Note: Coefficient estimates are from separate fixed effect linear probability
regressions of the aggregate PSIs on dummies indicating adoption of CPOE and its
interaction with different measures for patient complication (X), along with dummies
variables for 1 or 2 years before adoption (Lead12), and 3 or 4 years before adoption
(Lead34), and their interaction terms with X . All regressions control for hospital
fixed effects, year fixed effects, patient characteristics, X, a group specific year fixed
effects (X ‚àó I_year). All standard errors are clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

45

Table 9: Effect of EMR Adoption on Patient Composition
CPOE
PhysDoc

CPOE
PhysDoc

Age

Male

Medicare

Medicaid

-.123
(.206)
.268
(.268)

-.006
(.005)
.002
(.007)

-.001
(.006)
.012
(.008)

.002
(.003)
-.001
(.004)

Self-Pay

White

Black

-.004
(.002)
-.001
(.003)

-.024
(.017)
.050**
(.020)

.001
(.004)
.003
(.004)

-.002
(.003)
-.003
(.003)

Co
morbidities
-.006
(.017)
.033
(.022)

# of
Patients
18.258
(31.709)
30.430
(36.941)

NonComplex
-.001
(.007)
-.014**
(.007)

Common
DRG
-.002
(.007)
.003
(.007)

Low
Mortality
-.002
(.006)
-.005
(.006)

PrivatePay
.001
(.005)
-.005
(.007)

Hispanic
CPOE
PhysDoc

CPOE
PhysDoc

Non-Elder
-.000
(.006)
-.004
(.006)

Low Severity
-.010
(.007)
.003
(.007)

Note: Coefficient estimates are from separate hospital-year level
regressions of a set of mean patient composition metrics on
dummies indicating adoption of CPOE and Physician
Documentation. All regressions control for hospital fixed effects
and year fixed effects. All standard errors are clustered at the
hospital level.
*** - p<.01, ** - p < .05, * - p < .10

46

Table 10: Differential Effects by Years since Adoption
(1)
CPOE
Year 1
Year 2
Year 3
CPOE*X
Year 1
Year 2
Year 3

-.146
(.099)
-.149**
(.074)
-.148
(.116)

(2)

(3)

(4)

(5)

(6)

-.059
(.097)
-0.078
(.084)
-0.136
(.119)

-.077
(-.085)
-0.100
(.079)
-.080
(.116)

-.100
(.104)
-.132
(.080)
-.117
(.121)

.086
(.114)
.055
(.128)
.022
(.142)

-.035
(.095)
-.008
(.093)
-.041
(.117)

-.147***
(.053)
-.118
(.086)
-.028
(.056)

-.126*
(.067)
-.097
(.081)
-.142
(.060)

-.139**
(.062)
-.052
(.070)
-.094
(.068)

-.370***
(.134)
-.328**
(.151)
-.278*
(.143)

-.289***
(.252)
-.378***
(.131)
-.289**
(.115)

2.95*
4.89**
3.24*
NonComplex

5.54**
5.28**
3.31*
CommonDrg

5.59**
10.15***
3.86**
LowMortality

5.78**
13.76***
5.12**
NonSevere

F-stat of CPOE+CPOE*X=0
Year 1
3.73*
Year 2
5.06**
Year 3
1.86
NonX= 1 if‚Ä¶
Seniors

Note: Coefficient estimates are from separate fixed effect linear probability
regressions of the aggregate PSIs on dummies indicating adoption of CPOE
(including one year, 2 years, and 3 or more years since adoption) and their
interactions with different measures for patient complication (X). All regressions
control for hospital fixed effects, year fixed effects, patient characteristics, X, a group
specific year fixed effects (X ‚àó I_year). All standard errors are clustered at the hospital
level.
*** - p<.01, ** - p < .05, * - p < .10

47

Table 11: Additional Levels of Heterogeneity
CPOE (a1)
CPOE*Non-Elderly (a2)

(1)

(2)

(3)

(4)

(5)

-.036
(.082)
-.077*
(.041)

-.003
(.081)
.022
(.042)
-.092*
(.050)
-.112**
(.056)

.006
(.087)
-.075
(.046)
-.114*
(.062)
-0.027
(.051)

.097
(.097)
.195***
(.071)
-.303***
(.098)
-.221***
(.073)

.056
(.086)
-0.013
(.048)
-.332***
(.093)
-0.005
(.051)

1.84

0.06

0.63

7.03***

0.29

1.06

1.71

5.01**

7.17***

4.18**

6.59**

6.44**

8.59***

NonComplex

CommonDrg

LowMortality

NonSevere

CPOE*X (a3)
CPOE*Non-Elderly*X (a4)
F-stat of:
Complicated non-Seniors:
a1+a2=0
non-Complicated Seniors:
a1+a3=0
Non-Complicated Non-Seniors:
a1+a2+a3+a4=0
X= 1 if‚Ä¶

Note: Coefficient estimates are from separate fixed effect linear probability regressions of the
aggregate PSIs on dummies indicating adoption of CPOE, its interactions with different
measures for patient complication (X) and a dummy for non-elderly. All regressions control
for hospital fixed effects, year fixed effects, patient characteristics, X, a group specific year
fixed effects (X ‚àó I_year), non_elderly ‚àó I_year and non_elderly ‚àó X ‚àó I_year; All standard
errors are clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

48

Table 12: Alternative Outcomes
Inpatient Mortality
CPOE

(0)

(1)

(2)

(3)

(4)

(5)

.026
(.028)

.036
(.040)
-.027
(.043)

.031
(.038)
-.021
(.037)

.036
(.032)
-.013
(.037)

.029
(.065)
-.016
(.086)

.029
(.036)
-.014
(.051)

0.07

0.11

0.48

0.11

0.18

-.274
(.435)

-.061
(-.470)

.094
(.416)

.846
(.689)

.650
(.465)

-.257

.321

-1.459**

-2.017***

-2.761***

(.418)

( .509)

(.612)

(.810)

(.760)

1.53
NonElderly

0.44
NonComplex

5.25**
CommonDrg

6.36**
LowMortality

11.78***

CPOE*X
F-stat of:
CPOE+CPOE*X=0
Length of Stay (logarithm)
CPOE

CPOE*X

F-stat of:
CPOE+CPOE*X=0
X= 1 if‚Ä¶

-.396
(.379)

Non-Severe

Note: Coefficient estimates are from separate fixed effect linear probability regressions of
inpatient mortality and length of stay on dummies indicating adoption of CPOE and its
interaction with different measures for patient complication (X). All regressions control
for hospital fixed effects, year fixed effects, patient characteristics, X, a group specific
year fixed effects (X ‚àó I_year). All standard errors are clustered at the hospital level.
*** - p<.01, ** - p < .05, * - p < .10

49

Appendix Table 1: Descriptions of Patient Safety Indicators
PSI #
9
10

11

PSI Name
Postoperative Hemorrhage or
Hematoma
Postoperative Physiological and
Metabolic Derangement

Description
Bleeding or bruising after an operation
Deficiency in the amount of oxygen reaching
body tissues or other physiological
complications
Conditions that affect breathing function or the
lungs themselves
Blockage of main artery of the lung or one of
its branches by a substance that has travelled
from elsewhere in the body or a blood clot in a
deep vein

12

Postoperative Respiratory
Failure
Postoperative Pulmonary
Embolism or Deep Vein
Thrombosis

6

Iatrogenic Pneumothorax Rate

a condition in which air or gas is present in the
pleural cavity as a result of mechanical
ventilation, tracheostomy tube placement, or
other therapeutic intervention

7

Central Venous Catheter-Related
Blood Stream Infection

8

Postoperative Hip Fracture Rate

15

Accidental Puncture or
Laceration Rate

Blood infection arising from the tubular,
flexible surgical instrument that is inserted into
a cavity of the body to withdraw or introduce
fluid.
Hip fractures after an operation when hip
fracture was not present on admission
excluding some cases such as muscular
disorders or violent seizures where fracture
may not be fault of hospital
Accidental puncture or cut during procedure

50

